Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection

about

Recent advances in understanding and managing infectious diseases in solid organ transplant recipients.

P2860

Q55084357-620BED9B-C946-4AB2-98C3-89A096A46242

P2860

Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection

Item

http://www.wikidata.org/entity/Q40446799

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Case report: Brincidofovir-ind ...... t of cytomegalovirus infection

@en

type

Item

label

Case report: Brincidofovir-ind ...... t of cytomegalovirus infection

@en

prefLabel

Case report: Brincidofovir-ind ...... t of cytomegalovirus infection

@en

P1476

Case report: Brincidofovir-ind ...... t of cytomegalovirus infection

@en

P2093

Annie Dewilde

http://www.w3.org/2001/XMLSchema#string

Arnaud Lionet

http://www.w3.org/2001/XMLSchema#string

Celine Goeminne

http://www.w3.org/2001/XMLSchema#string

Célia Lessore de Sainte Foy

http://www.w3.org/2001/XMLSchema#string

Johana Béné

http://www.w3.org/2001/XMLSchema#string

Mohamed Lasri

http://www.w3.org/2001/XMLSchema#string

Olivier Cannesson

http://www.w3.org/2001/XMLSchema#string

Sophie Alain

http://www.w3.org/2001/XMLSchema#string

Tatiana Galperine

http://www.w3.org/2001/XMLSchema#string

P2860

A method for estimating the probability of adverse drug reactions

Use of leflunomide in renal transplant recipients with ganciclovir-resistant/refractory cytomegalovirus infection: a case series from the University of Chicago.

First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses.

Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art.

Management of cytomegalovirus infection in solid organ transplantation.

Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies.

The Revised (2013) Banff Classification for Antibody-Mediated Rejection of Renal Allografts: Update, Difficulties, and Future Considerations.

Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis.

Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure.

Tubular cell apoptosis and cidofovir-induced acute renal failure.

P304

e5226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1097/MD.0000000000005226

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Emmanuel Faure

Viviane Gnemmi

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27858871

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

5591119

http://www.w3.org/2001/XMLSchema#string

Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection

about

P2860

P2860

Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932